ロード中...
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are important for tumorigenesis has emerged as a potential therapeutic strategy for cancer. PROTACs are heterobifunctional molecules consisting of one ligand for binding to a protein of interest (POI) and another to an E3 ubiqui...
保存先:
| 出版年: | Oncogene |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7319888/ https://ncbi.nlm.nih.gov/pubmed/32475992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1336-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|